X

Vous n'êtes pas connecté

Maroc Maroc - MEDINDIA.NET - Medindia Health News - 20/Aug 18:16

India's First Dengue Vaccine on Its Way! Phase III Clinical Study Initiated

Indian Council of Medical Research (ICMR) and Panacea Biotec declared the start of Phase III clinical trial for India's first dengue vaccine.

Articles similaires

Sorry! Image not available at this time

Clinical Pharmacist – Operations Manager at IQVIA

jobwebkenya.com - 19:05

IQVIA, formerly Quintiles and IMS Health, Inc.,is an American multinational company serving the combined industries of health information technology...

Bharat Biotech, Alopexx Inc of US to co-develop, commercialise anti-microbial vax AV0328

times of india - 09:13

Bharat Biotech has teamed up with Alopexx Inc to co-develop and market the broad-spectrum antimicrobial vaccine AV0328 in India and other low-income...

Bharat Biotech, Alopexx Inc of US to co-develop, commercialise anti-microbial vax AV0328

times of india - 09:13

Bharat Biotech has teamed up with Alopexx Inc to co-develop and market the broad-spectrum antimicrobial vaccine AV0328 in India and other low-income...

Sorry! Image not available at this time

RZLT Stock Up as FDA Lifts Clinical Holds on Rare Disease Study

zacks.com - 10/Sep 14:44

The FDA removes the partial clinical holds on Rezolute's phase III study evaluating RZ358 for treating congenital hyperinsulinism.

Sorry! Image not available at this time

RZLT Stock Up as FDA Lifts Clinical Holds on Rare Disease Study

zacks.com - 10/Sep 14:44

The FDA removes the partial clinical holds on Rezolute's phase III study evaluating RZ358 for treating congenital hyperinsulinism.

Courting misinformation

newsday.co.tt - 07:39

WITHOUT FACTS, there is no health care. Doctors need to examine patients. Samples need to be checked in laboratories. Studies must be conducted to...

Opposition Leader criticises health care system

newsday.co.tt - 06:45

Opposition Leader Kamla Persad-Bissessar has criticised the government for its handling of the healthcare system, particularly during covid19. She...

Dimerix first patient completes Phase 3 trial and enters into long-term DMX-200 Open Label Extension study

stockhead.com.au - 10/Sep 23:38

Dimerix has enrolled the first patient into the Open Label Extension study for its kidney disease drug candidate DMX-200 after ...

Les derniers communiqués

  • Aucun élément